Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cannabinoid Hyperemesis Syndrome”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Large-scale testing (Phase 3)Looking for participantsNCT07246187
What this trial is testing

Comparing Haloperidol to Olanzapine in the Treatment of Suspected Cannabinoid Hyperemesis in the Emergency Department

Who this might be right for
Cannabinoid Hyperemesis Syndrome
Mercy Bon Secours Saint Vincent Medical Center 114
Not applicableEnrolling By InvitationNCT05812339
What this trial is testing

Body Surface Gastric Mapping to Evaluate Patients With Upper Gastrointestinal Symptoms and Controls

Who this might be right for
Motility DisorderGastroparesisFunctional Dyspepsia+3 more
University of Calgary 200
Post-approval studies (Phase 4)Study completedNCT04176055
What this trial is testing

Treatment Strategies in CHS

Who this might be right for
Cannabis Hyperemesis Syndrome
University of Calgary 4
Large-scale testing (Phase 3)UnknownNCT05244460
What this trial is testing

Droperidol on Prevention of Cannabis Hyperemesis Syndrome

Who this might be right for
Cannabis Hyperemesis Syndrome
Mercy Health Ohio 45
Not applicableLooking for participantsNCT06660901
What this trial is testing

Cannabinoid Hyperemesis Syndrome. Prospective Multicenter Study of Patients Admitted to Adult Emergency Departments in Maine-et-Loire.

Who this might be right for
D000096704Cannabinoid Hyperemesis Syndrome
University Hospital, Angers 3,000
Post-approval studies (Phase 4)Study completedNCT04283292
What this trial is testing

Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome

Who this might be right for
Cannabinoid Hyperemesis Syndrome
University of Virginia 20